Back to Alerts List

Forever Beautiful Bee Pollen by REFA Enterprises: Recall - Undeclared Drug Ingredients

[Posted 11/20/2014]

AUDIENCE: Consumer

ISSUE: REFA Enterprises is voluntarily recalling one lot each of:

Forever Beautiful Bee Pollen (UPC # 6333090804632)
Forever Beautiful Infinity (UPC # 633090804649)

The products have been found to contain undeclared Sibutramine or a combination of both Sibutramine and Phenolphthalein through FDA laboratory analyses.

Products containing sibutramine pose a threat to consumers because Sibutramine can increase blood pressure and/or pulse rate in some patients and may present a risk for those with a history of coronary artery disease, congestive heart failure, arrhymias or stroke. These products may also interact in life threatening ways with other medications a consumer may be taking. Health risks associated with phenolphthalein could include potentially serious gastrointestinal disturbances, irregular heartbeat, and cancer with long-term use.

BACKGROUND: Sibutramine is an appetite suppressant that was withdrawn from the U.S. market in October 2010 due to increased risk of seizures, heart attacks, arrhythmia and strokes. Phenolphthalein is an ingredient previously used in over-the-counter laxatives, but because of concerns of carcinogenicity, it is not currently approved for marketing in the United States.

Forever Beautiful Bee Pollen and Forever Beautiful Infinity are packaged in bottles of 60 capsules, and were distributed via internet to consumers nationwide from July 7, 2014 – November 3, 2014.

RECOMMENDATION: Consumers that have recalled product should stop using them, and return products to REFA Enterprises, LLC.

Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

Complete and submit the report Online: www.fda.gov/MedWatch/report.htm
Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178

[11/19/2014 - Press Release - REFA Enterprises]
[11/19/2014 - Product Photos - FDA]

Related Safety Alerts

E-cigarette: Safety Communication - Related to Seizures Reported Following E-cigarette Use, Particularly in Youth and Young Adults [Posted 4/3/2019]
Valsartan-Containing Products: Update Health Professional and Consumer on Recent Recalled Products [Posted 7/19/2018]
Kratom (mitragyna speciosa) Powder Products by Gaia Ethnobotanical: Recall - Due to Potential Salmonella Contamination [Posted 6/22/2018]
X-Jow and Acne Shave Products by Shadow Holdings: Voluntary Recall - Due to Possible Bacterial Contamination [Posted 5/29/2018]
95% Ethyl Alcohol Product by Ethanol Extraction: Recall - Due to a Possible Contamination with Methanol [Posted 5/23/2018]
Oral Over-the-Counter Benzocaine Products: Drug Safety Communication - Risk of Serious and Potentially Fatal Blood Disorder [Posted 5/23/2018]
Homeopathic Teething Drops, Nausea Drops, Intestinal Colic Drops, Stomach Calm, Expectorant Cough Syrup, Silver-Zinc Throat Spray, and Argentum Elixir by MBI Distributing: Recall - Due to a Lack of Adequate Controls [Posted 5/21/2018]
Rhino 69 Extreme 50000 by AMA Wholesale: Recall - Presence of Tadalafil [Posted 4/18/2018]
Euphoric Capsules by Epic Products: Recall - Undeclared Sildenafil and Tadalafil [Posted 4/18/2018]
Maeng Da Red Powder and Capsules by Club 13: Recall - Possible Contamination With Salmonella [Posted 4/10/2018]

Forever Beautiful Bee Pollen by REFA Enterprises: Recall - Undeclared Drug Ingredients

Related Safety Alerts

Registry Sponsors